Precision Medicine in Neurodevelopmental Disorders: Challenges and Opportunities
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 71
Special Issue Editors
2. Ph.D. Program in Biology-Neuroscience, Graduate Center of the City, University of New York, New York, NY 10016, USA
Interests: pathophysiological mechanism of orphan diseases; 17β-HSD10 deficiency; mental retardation; X-linked; syndromic 10; Alzheimer's disease
Interests: developmental disabilities; metabolic diseases; genetic disorders
Interests: beta-lactamases; on a steroid dehydrogenase (HSD10) in the brain; use bioinformatics methods in the study of protein structure and protein-ligand binding
Special Issue Information
Dear Colleagues,
The scientific reports included in this Special Issue show advances in studies on pediatric diseases with intellectual disability. Since Dr. George A. Jervis diagnosed the first case of alkaptonuria in the last century, more than a hundred disorders, such as fragile X, intellectual disability X-linked syndromic 10, and HSD10 deficiency, have been discovered. Major advances in medical science have provided opportunities to prevent such refractory diseases. This Special Issue of Journal of Personalized Medicine, “Precision Medicine in Neurodevelopmental Disorders: Challenges and Opportunities”, will promote the diagnosis and treatment of these diseases, helping patients with developmental disabilities to live richer lives.
Prof. Dr. Song-Yu Yang
Dr. Xue-Ying He
Prof. Dr. Manfred Philipp
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- intellectual disability
- inborn metabolic disorders
- X-linked disorders
- retarded growth
- mitochondrial diseases
- genetic and genomic disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
